Using antisera against growth hormone-releasing factor, cell bodies and axon processes were identified in the hypothalamus and the median eminence of the monkey Macaca irus. Cell bodies were located mainly in the arcuate nucleus and along the third ventricle wall, and occasionally in the ventromedial nucleus. Irnmunostained axons were also observed in the dorsolateral hypothalamus. No immunostained cell bodies were identified in the hypothalamic magnocellular nuclei (paraventricular, supraoptic and suprachiasmatic nuclei). In the median eminence, bundles of fibers were present in the external layer. These cell bodies and fibers did not react with antisera against neurophysin, somatostatin, gonadotropin-releasing hormone, and corticotropin-releasing factor.
The presence in hypothalamic extracts ofa factor that stimulates the release of pituitary growth hormone (GH) has been suspected for many years (1 l, 34; for reviews, see 1, 27, 28, 32, 35, 36) . The nature of the substance controlling the GH release has long been the subject of discussions. In 1982 growth hormone-releasing factors (GRF) were isolated from human pancreatic tumors; these are three peptides containing respectively 44, 40 and 37 residues whose amino acid sequence is now known (12, 13, 17, 37) . The largest (hpGRF|_44-NHZ), referred to as somatocrinin, is considered to be the primary form of GRF (7, 25) . Rat GRF was characterized by Spiess er ai. (39) , and a high molecular weight GRF was isolated by Sykes and Lowry (40) from pig hypothalamus. In human hypothalamus, two forms of GRF identical to tumor-derived GRFL44-NH; and GRFM0 were identified (6). Human GRF was recently synthetized (15, 24; for reviews, see 18, 19) . Immunocytochemical localization of immunoreactive GRF-containing neurons and fibers has been reported in hypothalamus and median eminence in the human (3, 4, 8, 9, 26, 31) , the monkey (2, 22), the rat (5, 20, 29, 30, 41) , the guinea pig (41), the garden dor-mouse (14), the cat (10), the dog (14), the codfish (33). In the present work, we describe the distribution of GRF-immunoreactive structures in the monkey Macaca irus hypothalamus and median eminence.
MATERIALS AND METHODS

Animals and Preparation of Tissues
Six adult male and female monkeys (Macaca irus) were used. Under Nembutal anesthesia, brains were rapidly removed and blocks containing hypothalamic region were quickly dissected. Tissue samples were fixed by immersion in Gérard's fluid (Bouin-Hollande-sublimate without acetic acid), embedded in Paraplast, and serially sectioned (10 am thick) in the frontal plane.
Reagenis
Three antisera against hpGRF were used (lots 451-7, 544-8, and 456-7, a generous gift from Dr P. Brazeau who prepared antibodies with the synthetic hpGRF,.40). According to Brazeau (personal communication), these antisera were monospecific for hpGRF1_44-NH; in radioimmunoassays at dilution of 1 :50,000 to 1 : 100,000. Antisera against neurophysin, somatostatin, gonadotropin-releasing hormone (Gn-RH) (donated by M. P. Dubois, Nouzilly, France), and corticotropin-releasing factor (donated by J. Barry, Lille, France) were also used for comparative topographical studies.
Immunostaining
The immunoperoxidase method was used for the demonstration of different peptides according to the procedure previously published (16). Antisera against these peptides were diluted 1:500 to l:l,500. The same staining protocol was used for all the peptides, namely, incubation in the first antibody overnight at 4°C, and in the second antibody for 1 h (in moist chambers). After each incubation, the sections were rinsed in fresh Tris buffer at pH 7.6 for 10-15 min. Peroxidase was revealed with 0.2% of 3,3'-diaminobenzidine tetrahydrochloride (DAB) in Tris buffer and 0.007% of H202 for 5 min at room temperature. After incubation in DAB, the sections were washed in Tris buffer, then in distilled water; nuclei were stained with Harris' haematoxylin for 20 sec, then rinsed in tap water. Sections were dehydrated, cleared in methyl cyclohexane, and covered with Entellan. Photographs were taken on Kodachrome 25 films using a Zeiss photomicroscope.
Controls of Specificity
The specificity ofthe immunocytochemical reaction was checked by 1) using normal human serum instead of antihormone serum; 2) omitting the anti-hpGRF antiserum; 3) using the anti-hpGRF serum preabsorbed overnight with hpGRF1_44-NH; (code No. 92-131-4G-30-34) (a gift from Dr R. Guillemin) (20 pg/ml of antiserum diluted 1:500).
RESULTS
GRF immunoreactivity was detected in numerous perikarya, in axons, and in dense bundles of fibers terminating in the median eminence.
The majority of immunoreactive cell bodies were located in the arcuate nucleus and along the wall ofthe third ventricle ( Fig. 1 ). They appeared more or less elongated and frequently bipolar in shape (Figs. 2 and 3). Some cell bodies were located in the ventromedial nucleus. Some dispersed varicose processes were observed in . ã. a . , , , ,
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.,-, . The intensity of immunostaining varied from one neuron to another. Immunoreactive cell bodies were not detected either in the paraventricular nucleus or in supraoptic or suprachiasmatic nuclei. Occasionally, isolated cell bodies were found in the posterior hypothalamus. On adjacent serial sections, hypothalamic neurons immunostained with anti-hpGRF were observed to differ from neurons reacting with anti-neurophysin, anti-somatostatin, anti-GnRH, and anti-CRF antibodies.
In the median eminence, bundles of fibers appeared in the external layer (Figs. 6 and 7). These fibers were distinct from somatostain, GnRH-and CRF-immunoreactive fibers.
No immunoreactive perikarya or neuronal processes were observed when the primary antiserum was omitted or replaced with normal human serum or when this antiserum was preabsorbed with specific antigen.
DISCUSSION
From previous immunocytochemical investigations and/or results by radioimmunoassays, some conclusions can be drawn. With regard to our observations both similarities and differences are found.
In the squirrel monkey, Bloch et al. (3) have described a small number of immunoreactive perikarya only in the arcuate nucleus; the immunostained neurons appeared more abundant in this region after intraventricular injection of colchicine 7 h and 24 h before removing the hypothalamus. In this primate, the authors have observed two anterolateral bundles of immunoreactive fibers in the posterior part ofthe median eminence. In the rhesus monkey, Lechan et ai. ." " . . within median eminence' (without further precise description). In human hypothalamus, using an antiserum to synthetic hpGRF1_44, Bresson et ai. (8, 9) have detected immunoreactive perikarya in the mediobasal region of fetuses (on and after the 18th week of gestation), of the newborn and adults; they have observed immunoreactive fibers around intraeminential portal vessels. According to Bloch et ai. (4), immunoreactive neurons with antibodies against hpGRF1_4(,-OH and hpGRF1_44-NH, were detected in human fetuses only on and after the 29th week; in fetuses, neonates, infants, and adults, immunoreactive neurons were located mainly in the arcuate nucleus and occasionally in the ventromedial nucleus. Similar results were reported by Marshall et ai. (26) in adult human hypothalamus: the most numerous immunoreactive perikarya were seen in the arcuate nucleus but additional immunoreactive cells were visualized in the periventricular zone. In the median eminence, these authors have observed numerous immunoreactive fibers in the external zone with axons terminals associated with portal vessels. According to Mouri er ai. (31) , the adult human hypothalamus contains immunoreactive cell bodies only in the arcuate nucleus. Using radioimmunoassay, Leidy and Robbins (23) have localized the majority of hpGRF1_44-like immunoreactivity in ventral and infundibular regions of human hypothalamus. Also with radioimmunoassays, Shibasaki er ai. (38) have determined that the highest concentrations of GRF-like immunoreactivity were found in extracts of human pituitary stalk (4.57-7.38 nglmg protein), whereas the hypothalamus contained fairly high concentrations ofGRF-like immunoreactivity (0.54-1.46 ng/mg protein).
From numerous research reports devoted to immunocytochemical detection of GRF in the rat hypothalamus, the following results can be underlined. Immunoreactive cell bodies are present, only in colchicine-treated animals, in the arcuate nucleus and sometimes at the periphery of the ventromedial nucleus and dorsal part of the dorsomedial nucleus (20), or in the arcuate nucleus and in ventral and dorsolateral hypothalamus (5). Weakly immunoreactive perikarya scattered in the arcuate nucleus (41), presence of immunoreactive perikarya in the arcuate nucleus and lateral basal hypothalamus, and some scattered cell bodies in paraventricular and dorsomedial nuclei (29, 30) have also been reported. Using radioimmunoassays, Kita et ai. (21) did not observe GRF-like immunoreactivity in para-157 ventricular, periventricular, suprachiasmatic or premamillary ventral nuclei, whereas this immunoreactivity was abundant in the arcuate nucleus. Indeed, according to Yasuda er ai. (43), if GRF concentration of the median eminence was taken as 100% in radioimmunoassays, the relative concentration in the paraventricular nucleus was 2.71%, whereas in medial hypothalamus (arcuate and ventromedial nuclei) the concentration was 0. Such a result differs dramatically from immunocytochemical and other radioimmunological observations. All these authors have underlined the abundance of nerve terminals (or GRF-like immunoreactivity in radioimmunoassays) in the rat median eminence. In particular, the results of Jacobowitz et al. (20) are worth considering. In various regions of the hypothalamus (paraventricular, periventricular, dorsomedial and ventromedial nuclei), a system of varicose nerve fibers, immunostained with anti-hpGRF1_44 serum, was also stained with the same antibody preabsorbed with hpGRF, unlike eminential fibers whose staining disappeared following use of preabsorbed antibody; the significance ofthe former system is not clear.
' In other mammalian species, cell bodies and neuronal processes were revealed with anti-hpGRF sera: in the guinea pig hypothalamus, immunostained perikarya were exclusively located in the arcuate nucleus (41); in the garden dormouse (Eliomys quercinus), such perikarya were visualized mainly in the paraventricular nucleus and occasionally in the supraoptic nucleus (14); in the cat (young animals aged 15 days, 1 month and 1.5 month), immunostained perikarya were scattered in paraventricular, supraoptic, infundibular (arcuate), dorsomedial nuclei and anterior periventricular area (10). In a teleost (codfish), immunostained perikarya were demonstrated using an anti-hpGRF,_40-OH serum in the preoptic area of the hypothalamus, whereas an antiserum against hpGRF1_44-NH; immunostained cell bodies in the rostral pars distalis (33).
Thus, it is now established that the hypothalamus ofvarious species, including man, contains a neuronal system involved in the biosynthesis of GRF. The main area ofdistribution ofthese neurons seems to be the arcuate nucleus. The quantitative importance of nerve fibers in the median eminence suggests that the peptide plays a physiological role in the control of GH secretion by the anterior lobe of the adenohypophysis via the hypothalamohypophyseal vascular system. The significance of distribution of other neuronal processes not included in the hypothalamo-
